A Phase Ib Study of the Combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A Phase Ib Study of the Combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs
Authors
Keywords
Afatinib, Ruxolitinib, EGFR, T790M, Non-Small cell lung cancer (NSCLC)
Journal
LUNG CANCER
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-05-28
DOI
10.1016/j.lungcan.2019.05.030

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.